Challenges in clinical trial design for HIV-1 cure research
Lancet
.
2013 Nov 2;382(9903):1464-5.
doi: 10.1016/S0140-6736(13)62040-1.
Authors
Nir Eyal
1
,
Daniel R Kuritzkes
Affiliation
1
Division of Medical Ethics, Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA.
PMID:
24182529
DOI:
10.1016/S0140-6736(13)62040-1
No abstract available
MeSH terms
AIDS Vaccines
Clinical Trials as Topic / ethics*
Clinical Trials as Topic / methods
Disease Eradication
HIV Infections / prevention & control*
HIV-1*
Humans
Research Design
Substances
AIDS Vaccines